CORRESP Filing
Processa Pharmaceuticals, Inc.
Date: June 13, 2025 · CIK: 0001533743 · Accession: 0001641172-25-015054
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-287997
Letter
Re: Processa Pharmaceuticals, Inc.
June 13, 2025
VIA FACSIMILE AND EDGAR
U.S. Securities and Exchange Commission
Division of Corporate Finance
Washington, DC 20549
Registration Statement on Form S-1 (Registration No. 333-287997) -
Concurrence in Acceleration Request
Ladies and Gentlemen:
H.C. Wainwright & Co., LLC (" Wainwright "), solely acting as placement agent on a best-efforts basis in an offering pursuant to the registration statement on Form S-1 (333-287997) (the " Registration Statement "), hereby concurs in the request by Processa Pharmaceuticals, Inc. that the effective date of the above-referenced registration statement be accelerated to 5:15 P.M. Eastern Time on Monday, June 16, 2025, or as soon as practicable thereafter, pursuant to Rule 461 under the Securities Act. Wainwright affirms that it is aware of its obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration Statement.
Very truly yours,
H.C. WAINWRIGHT & CO., LLC
Show Raw Text
CORRESP
1
filename1.htm
June
13, 2025
VIA
FACSIMILE AND EDGAR
U.S.
Securities and Exchange Commission
Division
of Corporate Finance
Washington,
DC 20549
Re:
Processa Pharmaceuticals, Inc.
Registration
Statement on Form S-1 (Registration No. 333-287997) -
Concurrence
in Acceleration Request
Ladies
and Gentlemen:
H.C.
Wainwright & Co., LLC (" Wainwright "), solely acting as placement agent on a best-efforts basis in an offering
pursuant to the registration statement on Form S-1 (333-287997) (the " Registration Statement "), hereby concurs
in the request by Processa Pharmaceuticals, Inc. that the effective date of the above-referenced registration statement be accelerated
to 5:15 P.M. Eastern Time on Monday, June 16, 2025, or as soon as practicable thereafter, pursuant to Rule 461 under the Securities Act.
Wainwright affirms that it is aware of its obligations under the Securities Act as they pertain to the best efforts offering pursuant
to the Registration Statement.
Very truly yours,
H.C. WAINWRIGHT & CO., LLC
By:
/s/
Edward D. Silvera
Name:
Edward D. Silvera
Title:
Chief Operating Officer
430 Park Avenue | New York, NY 10022 | 212.356.0500
| www.hcwco.com
Member: FINRA/SIPC